Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 23 04:00PM ET
Dollar change
Percentage change
IndexS&P 500 P/E43.05 EPS (ttm)8.25 Insider Own6.19% Shs Outstand380.10M Perf Week1.79%
Market Cap135.00B Forward P/E26.70 EPS next Y13.30 Insider Trans-1.55% Shs Float356.74M Perf Month15.36%
Income3.17B PEG3.91 EPS next Q2.36 Inst Own81.37% Short Float1.17% Perf Quarter20.90%
Sales20.50B P/S6.59 EPS this Y11.94% Inst Trans1.53% Short Ratio3.00 Perf Half Y28.65%
Book/sh48.92 P/B7.26 EPS next Y12.05% ROA8.24% Short Interest4.18M Perf Year35.69%
Cash/sh8.03 P/C44.22 EPS next 5Y11.02% ROE17.98% 52W Range249.98 - 354.82 Perf YTD18.56%
Dividend Est.2.61 (0.73%) P/FCF43.05 EPS past 5Y-2.45% ROI10.60% 52W High0.06% Beta0.90
Dividend TTM3.05 (0.86%) Quick Ratio0.97 Sales past 5Y8.80% Gross Margin60.89% 52W Low42.02% ATR (14)5.98
Dividend Ex-DateMar 27, 2024 Current Ratio1.58 EPS Y/Y TTM33.73% Oper. Margin21.16% RSI (14)76.98 Volatility1.42% 1.65%
Employees52000 Debt/Eq0.73 Sales Y/Y TTM11.11% Profit Margin15.44% Recom1.86 Target Price362.50
Option/ShortYes / Yes LT Debt/Eq0.61 EPS Q/Q102.17% Payout36.98% Rel Volume0.50 Prev Close353.15
Sales Surprise3.80% EPS Surprise5.85% Sales Q/Q11.78% EarningsJan 30 AMC Avg Volume1.39M Price355.03
SMA205.10% SMA5012.36% SMA20021.84% Trades Volume691,451 Change0.53%
Date Action Analyst Rating Change Price Target Change
Jan-31-24Upgrade Canaccord Genuity Hold → Buy $315 → $360
Oct-20-23Initiated ROTH MKM Buy $345
Sep-05-23Upgrade BofA Securities Neutral → Buy $310 → $315
Mar-29-23Initiated UBS Neutral $287
Jan-25-23Initiated KeyBanc Capital Markets Sector Weight
Jan-09-23Upgrade RBC Capital Mkts Sector Perform → Outperform $240 → $284
Nov-01-22Downgrade Canaccord Genuity Buy → Hold $225 → $220
Oct-18-22Initiated Barclays Overweight $239
Oct-12-22Initiated Jefferies Buy $270
Jul-28-22Upgrade Edward Jones Hold → Buy
Feb-22-24 05:25AM
Feb-18-24 01:26PM
Feb-15-24 12:07AM
Feb-13-24 02:41PM
05:06AM Loading…
Feb-07-24 08:00AM
Feb-05-24 08:00AM
Feb-01-24 03:03PM
Jan-31-24 07:29PM
08:10AM Loading…
Jan-30-24 11:06PM
Jan-29-24 08:22AM
Jan-25-24 10:50PM
Jan-24-24 11:25AM
05:16AM Loading…
Jan-22-24 05:16AM
Jan-18-24 08:50AM
Jan-17-24 08:00AM
Jan-15-24 10:03AM
Jan-12-24 03:49PM
Jan-10-24 08:35AM
Jan-08-24 07:20PM
Jan-05-24 08:00AM
Jan-04-24 07:09AM
Jan-02-24 12:10PM
Dec-27-23 05:03AM
Dec-20-23 06:06AM
Dec-19-23 05:00AM
Dec-18-23 09:00AM
Dec-07-23 08:00AM
Dec-06-23 08:00AM
Dec-05-23 08:00AM
Dec-04-23 07:27AM
Nov-26-23 05:56AM
Nov-20-23 06:52AM
Nov-15-23 07:00AM
Nov-09-23 12:09PM
Nov-04-23 01:21AM
Nov-03-23 06:30PM
Nov-02-23 06:20PM
Nov-01-23 08:42AM
Oct-31-23 07:37AM
Oct-30-23 04:05PM
Oct-26-23 10:02AM
Oct-25-23 05:59AM
Oct-24-23 04:57PM
Oct-17-23 11:32AM
Oct-12-23 08:35AM
Oct-11-23 12:07PM
Oct-09-23 04:05PM
Oct-05-23 09:35AM
Oct-04-23 07:39AM
Oct-03-23 09:04PM
Oct-02-23 04:05PM
Sep-29-23 04:05PM
Sep-28-23 07:03AM
Sep-26-23 12:33PM
Sep-25-23 11:40AM
Sep-22-23 09:49AM
Sep-21-23 07:06PM
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Boehnlein Glenn SVP, Chief Financial OfficerFeb 09Sale342.819,6003,290,95220,194Feb 12 04:09 PM
STRYKER RONDA EDirectorFeb 06Sale339.9592,29631,376,0213,662,832Feb 07 05:33 PM
Becker Yin CVP, Chief Corp Affairs OfficerFeb 05Option Exercise93.068,060750,06433,129Feb 07 05:00 PM
STRYKER RONDA EDirectorFeb 05Sale342.90201,14668,973,3603,755,128Feb 07 05:33 PM
Golston Allan C.DirectorFeb 02Option Exercise96.644,570441,64518,812Feb 06 05:24 PM
STRYKER RONDA EDirectorFeb 02Option Exercise81.144,355353,3657,642Feb 06 05:16 PM
Golston Allan C.DirectorFeb 02Sale341.003,2731,116,09314,242Feb 06 05:24 PM
Pierce James AndrewGroup PresidentJan 16Option Exercise81.1410,230830,06257,999Jan 16 04:23 PM
Boehnlein Glenn SVP, Chief Financial OfficerJan 11Option Exercise95.9960,0055,760,02268,981Jan 16 04:16 PM
Silvernail Andrew KDirectorDec 05Option Exercise81.144,355353,36511,472Dec 07 04:57 PM
Datar Srikant M.DirectorDec 04Option Exercise93.061,795167,0435,611Dec 05 04:25 PM
Datar Srikant M.DirectorDec 01Sale298.22500149,1123,816Dec 05 04:25 PM
Becker Yin CVP, Chief Corp Affairs OfficerNov 28Option Exercise81.148,875720,11830,806Nov 28 08:16 PM
Berry William E JrVP, Chief Accounting OfficerNov 28Sale292.28573167,4772,909Nov 28 08:09 PM
Boehnlein Glenn SVP, Chief Financial OfficerNov 27Option Exercise81.1411,955970,02916,570Nov 28 08:02 PM
Lobo KevinChair and CEONov 17Option Exercise81.14160,21512,999,845241,249Nov 21 05:18 PM
Stiles Spencer SGroup PresidentNov 17Option Exercise81.1411,090899,84353,732Nov 21 04:33 PM
Lobo KevinChair and CEONov 17Sale287.9156,48316,261,81281,034Nov 21 05:18 PM
Datar Srikant M.DirectorNov 16Sale291.92500145,9624,316Nov 16 05:56 PM
Datar Srikant M.DirectorNov 15Sale287.50500143,7514,816Nov 16 05:56 PM
Datar Srikant M.DirectorNov 14Sale287.57750215,6815,316Nov 16 05:56 PM
Menon VijuGroup PresidentSep 06Sale289.005,0001,445,0006,994Sep 08 04:20 PM
Datar Srikant M.DirectorAug 10Sale286.23750214,6716,066Aug 10 04:24 PM
Datar Srikant M.DirectorAug 08Option Exercise93.062,000186,1207,467Aug 10 04:24 PM
Datar Srikant M.DirectorJun 01Sale278.50500139,2505,467Jun 05 05:24 PM
Datar Srikant M.DirectorMay 18Sale286.001,000286,0005,967May 19 06:29 PM
Caforio GiovanniDirectorMay 04Option Exercise0.0084101,850May 08 04:29 PM
BRAINERD MARY KDirectorMay 04Option Exercise0.0084105,110May 08 04:22 PM
Suri RajeevDirectorMay 04Option Exercise0.0084104,510May 08 04:45 PM
Skeete Tatum Lisa MDirectorMay 04Option Exercise0.0084102,525May 08 04:40 PM
McCoy Sherilyn SDirectorMay 04Option Exercise0.0084104,510May 08 04:34 PM
Boehnlein Glenn SVP, Chief Financial OfficerMar 21Option Exercise0.0014907,902Mar 23 06:47 PM
STRYKER RONDA EDirectorMar 21Option Exercise0.001,04802,582Mar 23 07:16 PM
Stiles Spencer SGroup PresidentMar 21Option Exercise0.00107045,413Mar 23 07:11 PM
Pierce James AndrewGroup PresidentMar 21Option Exercise0.00107050,610Mar 23 07:07 PM
Menon VijuGroup PresidentMar 21Option Exercise0.0088013,861Mar 23 07:03 PM
Lobo KevinChair and CEOMar 21Option Exercise0.00504099,253Mar 23 07:00 PM
Fletcher Robert SVP, Chief Legal OfficerMar 21Option Exercise0.006509,030Mar 23 06:56 PM
Fink M KathrynVP, Chief HR OfficerMar 21Option Exercise0.0046010,974Mar 23 06:52 PM
Becker Yin CVP, Chief Corp Affairs OfficerMar 21Option Exercise0.0022022,496Mar 23 06:36 PM
Golston Allan C.DirectorFeb 28Option Exercise86.698,150706,52721,687Mar 01 05:47 PM
Golston Allan C.DirectorFeb 28Sale263.275,4591,437,18013,537Mar 01 05:47 PM